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 1 
INTRODUCTION 
 
Neurotoxic studies represent an especially important part within the whole complexity of 
investigating the biological interactions of living organisms and their environment. 
Nervous system plays an essential role in perception of relevant external stimuli and in 
shaping the organism’s adequate response to these in order to secure its survival. In case of 
humans, an improperly functioning nervous system may greatly affect the quality of life at 
individual level, and cause a loss of mental power, being perhaps the most valuable human 
resource at population level. 
Human environment (including workplaces, homes, outdoor areas etc.) can contain various 
neurotoxicants, being of both natural and synthetic origin, and exposing humans by inhalation, 
by consumption of foods and drinking water, or via the skin. The major groups of relevant 
toxicants include both organics and inorganics, mainly metals and metal compounds including 
manganese (Mn). 
In pure state, manganese (Mn) is a silvery-grey, hard and brittle metal. In such form it is not 
used but its alloys and compounds are found in numerous practical applications from 
steelmaking to nano-electronics. Mn shows various oxidation states between 2 and 7; which is 
of toxicological importance. It is an essential trace element for all living organisms but has 
toxic effects when overdosed. Ingested Mn is absorbed to 5-15% only, in a regulated process 
where Mn overload leads to decreased absorption rate. Parenteral absorption, e.g. after 
inhalation, can be much more efficient which also has toxicological relevance. 
One of the Mn containing enzymes, glutamine synthetase, is a glia-specific Mn-protein that 
catalyses the conversion (that is, inactivation) of the excitatory transmitter glutamate to 
glutamine. This enzyme requires Mn but is inhibited by Mn excess, resulting in neurotoxicity. 
Mitochondrial complex II and complex III can also be inhibited by Mn excess, leading to 
energy shortage and oxidative stress. The latter is counteracted (among others) by another 
Mn-enzyme, Mn-containing superoxide dismutase (Mn-SOD). Inhibited mitochondrial 
function probably blocks tyrosine hydroxylation which contributes to dopaminergic 
dysfunction, besides Mn-induced autooxidation of dopamine. 
Occupational Mn exposure typically means chronic inhalation of metal dusts and fumes (in 
jobs like welding, steel casting, ferromanganese production etc), and causes a state called 
manganism. This disease starts with nonspecific symptoms including apathy, anorexia, 
asthenia, headache, hypersomnia, spasms etc., and ends with a Parkinson-like syndrome. One 
of these symptoms is bradykinesia but in the early phase behavioral disinhibition with 
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hypermotility also occurs. And, in spite of the similar symptoms, the site of damage in 
manganism and in Parkinson’s disease is different, since Mn affects the striatal, and not the 
mesencephalic, dopaminergic neurons. Parkinson-like disorder caused by Mn was also 
observed in patients undergoing maintenance hemodialysis, or high oral doses e.g. from high-
Mn drinking water. 
The neurotoxic spectrum of Mn is variable. Beyond classical manganism it includes, among 
others, epileptic disorders, observed primarily in Mn-overexposed children or young adults. 
So, Mn is among the environmental factors occasionally causing epilepsy. Epilepsy is, 
defined by the International League Against Epilepsy, a brain disorder characterized by the 
prolonged or steady predisposition to produce epileptic seizures. These are in turn defined as 
transient occurrences of signs or symptoms of abnormal – excessive or hypersynchronous – 
activity of brain neurons. In exposed workers with elevated blood Mn level, 
electroencephalographic (EEG) and visual evoked potential alterations were also observed. 
The functional neurotoxicity of Mn has been investigated at the Department of Public Health 
for ca. 15 years. Electrophysiological and behavioral methods both brought a substantial 
amount of new information. However, comparison of effects on electrical activity and open 
field motility was encumbered by the fact that electrophysiological recording was done in 
anaesthesia and hence its data could not be directly put in parallel with the behavioral effects. 
In the meantime, it became possible to perform repeated simultaneous recording of cortical 
electrical activity (electrocorticogram, ECoG) and open field (OF) motility in awake rats. In 
the research work described in this thesis, rats prepared for such chronic recording were used, 
and Mn was administered to them for 4 to 8-10 weeks orally by drinking water or via the 
airways by intratracheal instillation. The particular aims of the work were: 
 
 To observe the development of the CNS effects of Mn in time; 
 To examine to what extent changes in motor behavior and in cortical electrical activity 
develop in parallel, and what relationship can be detected between the two; and 
 To examine whether the epileptogenic effect of Mn, mentioned in the literature, can be 
observed under the experimental conditions applied.  
 
METHODS 
 
To implement these aims, four experiments (summarized in the table 1) were performed on 
adult male rats. In Experiment 1, 2 and 3 these were Wistars of 10-11 weeks of age, with ca. 
350 g body weight, and were obtained from the breeding centre of the University of Szeged. 
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Rats of this age were needed because their skull bones are strong and no more growing. In 
Experiment 4, WAG/Rij rats were used (representing a strain specially developed to model 
human temporal lobe epilepsy, and showing short bursts of spike-and-wave discharges, SWD, 
in their cortical electrical activity). A stock of parent males and females was obtained from 
Charles River, Germany. They were bred several times with the maximal exclusion of in-
breeding, and the male offspring were used in the experiments. 
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Manganese treatment Number of rats evaluated 
Substance Dose Time 
Open Field 
and general tox. 
ECoG 
Treated Control Treated Control 
1 Wistar 
MnCl2, oral, 
by drinking 
water 
2.5 
mg/mL 
water 
4 
weeks 
4 4 3 3 
2 Wistar 
MnCl2, oral 
by drinking 
water 
7.5 
mg/mL 
water 
8 
weeks 
4 4 4 3 
3 Wistar 
MnO2 nano 
intratracheal 
2.63 
mg/kg. 
b.w. 
8 
weeks 
7 
4 (UnT) 
3 (VT) 
5 
3 (UnT) 
2 (VT) 
4 WAG/Rij 
MnCl2, oral 
by drinking 
water 
7.5 
mg/mL 
water 
8 
weeks 
4 3 4 3 
UnT, untreated control; VT, vehicle-treated control in Experiment 3. 
 
For repeated recording of ECoG, the rats were implanted with chronic electrodes and a 
connector “crown”, in an operation carried out under aseptic conditions in general anesthesia 
(isoflurane in 100% O2, 4.5% for induction and 2-3% for maintenance). 
After ca. 10 days recovery, one recording session per week was made. The first two were 
control sessions with one week interval and without any treatment. Then, Mn administration 
for the treated rats (and vehicle administration for the controls in Experiment 3) was started, 
and lasted as given in Table 1 with further recording sessions in one week intervals. The 
sessions lasted 30 (Experiment 1) or 60 (Experiment 2, 3 and 4) minutes. MnCl2 was 
dissolved in normal tapwater and given in the drinking bottle. In Experiment 3, MnO2 
nanoparticles of ca. 30 nm diameter were instilled in the treated rats’ trachea.  
OF activity of the rats was recorded in a black plastic box with 48x48x40 cm inner space, 
equipped with an array of infrared light gates at floor level. The instrument recorded and 
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analyzed the rat’s horizontal motor activity based on the interruptions of the infrared beams, 
using the software Conducta 1.3 (Experimetria Ltd, Hungary). Detection of vertical activity 
(rearing) was deliberately omitted because of the false signals the crown and cable would 
have produced. The room used for recording was lit dimly. The software automatically 
processed beam interruption data to numerical description of motility (ambulation, local 
activity or immobility; total time and event counts, plus ambulation distance). The data were 
obtained and evaluated for the whole 30 or 60 min session, and also in 3 min periods within a 
session to see short-term changes. 
The rat’s cortical electrical activity was taken up by a preamplifier mounted on the end of the 
flexible lead-off cable connected to the crown. The two lead-off points on the left and right 
hemisphere, respectively, provided one bipolar channel each. Overall amplification was 10
4 
x 
with high- and low-pass filters set to 1.6 and 75 Hz. The ECoG signals were visualized on the 
monitor of a PC in real time and stored on the hard disk, using the software Neurosys EEG 
v1.1.0.72 of Experimetria. No major difference between the electrical activity on the two 
channels was seen. So, signals of channel 1 (left hemisphere) were used for analysis of ECoG. 
From the ECoG records, the software calculated the continuous power spectrum with 0.5 Hz 
resolution and the total power between 1 and 49 Hz. The analysis was based on FFT 
technique. Evaluation was based on the shape of the power spectrum curve, and on difference 
spectra obtained as the ratio of a spectrum from a given phase of treatment and a control 
spectrum. Band spectra were obtained to see any correlation with variables of motility. The 
band limits were set as follows: delta , between 1 and 3.5 Hz; theta, between 4 and 7.5 Hz; 
alpha, 8-12 Hz; low beta, 12.5-15; mid beta, 15.5-18; high beta, 18.5-31, and gamma, 31.5-44 
Hz. The lower part of beta was cut in two bands to see better any change around 13-15 Hz 
where the epileptogenic effect of Mn typically appeared. Correlation between OF, ECoG and 
tissue Mn level data was tested by the “linear fit” function of Excel after plotting 
corresponding data pairs in an X-Y plot. 
Spectrum calculations were done for the whole, 30 or 60 minutes long, recording session, or 
for shorter periods. Three minute periods were used to see the change within one 30 or 60 min 
session; and 1 s resolution was used in Experiment 4 to obtain numerical data of the visually 
detected epileptic SWD burst. For that, the maximum and minimum of ECoG power in the 
12.5-18 Hz range (low and mid beta) was determined for every 1 s period, and the value of 
[(max-min)/2 + min]; called peak indicator, calculated. This value was then used to decide 
which seconds are to be regarded as belonging to a burst. The numerical criteria were set to 
achieve maximal agreement between the bursts observed on the ECoG and the calculations  
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Body weight data were plotted against the days of the experiment to obtain weight gain 
curves. Tissue Mn level determination was done by inductively coupled plasma mass 
spectrometry. 
Due to the small data pool, a simple statistical evaluation was done. Corresponding data of 
different groups (treated or control) were taken as one data set each and were compared by 
means of two-sample t-test (Experiment 1, 2 and 4) or one-way ANOVA (Experiment 3). 
Significance was accepted at p<0.05. 
 
RESULTS 
 
Body weight gain of the rats was not affected by Mn exposure in Experiments 1, 2 and 4. In 
Experiment 3, there seemed to be a minimal lag in weight gain in the treated rats which might 
have been due partly to the treatment procedure. There was, however, significant Mn 
deposition in the treated rats’ tissue samples (Table 2). 
 
Table 2 
  Tissue Mn level, µg/kg 
  Blood Brain Liver 
Exp. 1 
Control 
Treated 
181.46±60.17   984.71±132.56 7132.24±471.74 
281.35±63.62* 1931.88±156.93*** 8022.97±609.25* 
Exp. 2 
Control 181.46±60.17   984.71±132.56 7132.24±471.74 
Treated 502.42±114.98** 3394.55±358.72*** 11304.12±3042.25* 
Exp. 3 
Control (VT) 285.43±133.21 2072.53±358.16 7369.43±1837.86 
Mn-treated 979.08±389.31** 11210.89±1393.34*** 12309.07±1553.89* 
Exp. 4 
Control 385.86±131.78 2269.57±680.70 6865.94±920.33 
Treated 440.95±88.18 4983.24±2051.48* 11671.06±3192.37* 
Mean±SD, n: see Table 1. *, **, ***: p<0.05, 0.01, 0.001 vs. Control. 
 
It was one of the major findings of the work that these Mn levels were caused by highly 
dissimilar summed doses (Experiment 1: ca.1100 mg Mn in 4 weeks, oral; Experiment 2: ca. 
5700 mg Mn. in 10 weeks, oral; Experiment 3: ca. 40 mg Mn in 8 weeks, intratracheal). 
In Experiment 1, the treated rats’ OF motility was higher than that of the controls from the 
2nd treatment week on, and their habituation to the OF environment, characterized by the 
decrease of ambulation during a 30 min recording session, was also less. The numerical data 
of immobility showed an opposite trend. Overall cortical electrical activity, quantified as the 
 6 
total power in the 1-49 Hz range, decreased substantially in the treated rats by the end of the 
4th treatment week but did not change much in the controls. The difference spectra showed 
that the ECoG power decrease was present over the whole 1-49 Hz frequency range in the 
treated rats but it appeared first around the 7 Hz maximum. The time course of the OF 
parameters and the ECoG power during the 6 weeks suggested a correlation between the two. 
In fact, R
2
>0.5 was found for theta, high beta and gamma in the Mn-treated and for theta, 
alpha, mid beta and high beta in the control rats, for the correlation with the time of 
ambulation and immobility. 
In Experiment 2, the rats were exposed to 7.5 mg MnCl2/mL water for at least 8 weeks. Here, 
the Mn-treated rats showed mildly decreased motility towards the end of the exposure period 
(might be interpreted as transition to the later phase of Mn-induced Parkinson-like disorder). 
Ambulation time data of individual rats on the last week and Mn levels in the brain samples 
were correlated (R
2
>0.5). Within the 60 min recording sessions, immobility in the treated rats 
decreased less steeply than in the controls. Decrease in the ECoG total power (like in 
Experiment 1) was seen also only in the last recordings. The difference spectra showed 
gradually developing decrease of ECoG power in the Mn-treated rats, around the 7 Hz peak 
and above 30 Hz. 
In correspondence with the decreased gamma activity, correlation with good R
2
 values was 
found between the time trend of ECoG gamma band power and several OF parameters in the 
treated rats – even if the OF parameters themselves did not change significantly. This 
indicated that the correlation of two functional parameters, supposedly influenced by Mn, 
might be more sensitive than the parameters alone. Local activity time and ECoG total power 
showed fair correlation to brain Mn level. 
In this experiment, Mn dose and treatment time were apparently sufficient to provoke 
epileptiform activity. Towards the end of the treatment period, short series of spikes were 
observed in two of the four exposed rats,  similar to those seen in the WAG/Rij rats used in 
Experiment 4, and were coincident with decreased motility and a typical peak on the ECoG 
spectrum around 13 Hz. 
In Experiment 3, Mn treatment was done by intratracheal instillation of MnO2 nanoparticles, 
5 days per week, for 8-10 weeks. This resulted in higher inner Mn doses and stronger neuro-
functional alterations. The inner Mn dose was sufficient to induce significant hypomotility: 
decrease of ambulation time was seen in the 3rd week of the experiment, after only 5 days of 
Mn administrations. The decrease developed further in the first 4-5 weeks of treatment but 
showed minimal change afterwards. A similarly manifest but opposite trend was seen in 
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immobility, and immobility also showed more intense increase during a 60 min recording 
session. 
ECoG total power increased starting with the 4th week of Mn exposure. Maximal increase 
was seen in the 7th week; after that, some decrease followed. The direction of ECoG total 
power change was opposite to that seen in the previous experiments and supported what was 
suggested by the OF data, namely that with various inner Mn doses not only the strength but 
also the direction of the Mn-induced functional changes can vary. The difference spectra 
showed stability in untreated controls. In vehicle treated rats, there were deviations indicating 
alteration vs. the pre-treatment period but without a clear trend. In Mn-treated rats, however, 
the difference curves showed a gradually developing power increase which resulted in the 
relative reduction of the 7 Hz peak. 
Ambulation distance, time and count had fairly good correlation to brain Mn levels. The 
correlation of ambulation distance and time, and immobility time, with low beta, mid beta and 
high beta power in the treated rats was strong (R
2
>0.5).  
From two treated rats in Experiment 3, tail vein blood was taken on the 4th and 8th week. The 
measured Mn level in these samples and in the final blood sample (10th week) were 
correlated to ambulation distance and to ECoG total power, suggesting that the non-linear 
time trend of OF and ECoG was due to a non-linear trend of Mn deposition in the rats’ body. 
In this experiment, the kind of epileptiform activity observed earlier (short series of spikes on 
the ECoG) were occasionally seen. The epileptogenic action of Mn was further investigated in 
the next experiment whether and how Mn exposure alters the spontaneous epileptic activity of 
WAG/Rij rats, in: 
Experiment 4. In the Mn-treated WAG rats, decrease of ambulation and increase of 
immobility during the weeks of Mn exposure – due partly to habituation and partly to aging – 
was much less than in the controls. Also, the increase of immobility within one 60 min 
recording session became more pronounced in the controls as the weeks elapsed but in the 
treated rats the trend was opposite. 
Total ECoG power increased massively in the treated rats on commencing the Mn exposure. 
This was not reflected in the general shape of power spectra but the difference spectra and 
their time trend were markedly dissimilar in the treated and control rats. The difference 
spectra of the Mn-treated WAG rats were partly similar to those in Experiment 2 and 3 which 
is another indication of the latent epileptogenic effect of Mn in those experiments. 
In the treated rats, the time spent in ambulation and in immobility was strongly correlated to 
ECoG total power and to the power of the low beta band. These OF parameters were also 
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strongly correlated to brain Mn level, whereas the correlation of ECoG low beta power to 
brain Mn was weaker. 
The ECoG of WAG rats is characterized by short (5-15 s) bursts of SWDs, during which a 
peak appears on the ECoG power spectrum around 13-15 Hz (approximately the the low beta 
band). The ECoG power spectrum underlined the importance of low beta. In silent phase, the 
peak around 7 Hz was visible, while in high-amplitude irregular activity the elevation of the 
spectrum curve right of the peak made the peak disappear. Typically this activity appeared 
when the initial exploratory reaction of the animal put into the OF box was over. During a 
burst, the 13-15 Hz peak was present. Hence, the power in the low and mid beta band was 
used to measure the intensity of epileptic activity. ECoG low beta power during the bursts 
increased more than the number of bursts itself. Especially the power for one bursting second 
increased in the treated rats, indicating that bursting – manifested in frequent and high-
amplitude deflections from the isoelectric line – was more intense under Mn influence. The 
ratio of low beta power in bursting/silent seconds was, on the contrary, higher in the controls, 
probably because in the Mn-treated rats the high-amplitude irregular cortical activity was 
more abundant in non-bursting periods. 
 
DISCUSSION 
 
In all four experiments, administration of Mn in different chemical forms and doses resulted 
in significant tissue Mn deposition (inner dose) and in alterations of CNS functional 
parameters. Body weight gain and organ weights indicated no noteworthy general toxicity 
even at the highest inner doses in Experiment 3 which suggested there was no major general 
toxic effect of Mn that could be responsible for the observed neuro-functional effects. 
Based on the correlations observed in each experiment, one can broadly state that the changes 
in OF motility and in cortical electrical activity developed in parallel. The neuro-functional 
effects were apparently highly dependent on the inner Mn doses and on the length of 
exposure; not only in terms of strength but also in direction. In Experiment 1 (where the dose 
and time of Mn exposure, and the resulting inner dose, was the lowest) treated rats had higher 
OF motility vs. the controls, which could be likened to the early phase of adult human 
manganism, characterized by behavioral disinhibition, and to attention deficit and 
hyperactivity observed in children consuming high-Mn drinking water. 
In Experiment 2, and even more in Experiment 3, the dose and length of Mn exposure was 
longer and the final tissue Mn levels were sufficient to induce the late “established” stage of 
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Mn-induced Parkinson-like disorder. There were more expressed alterations in the first ca. 4 
weeks of exposure than afterwards, possibly due to decreased absorption and/or increased 
excretion of Mn. In Experiment 3, the actual ambulation time and in ECoG total power data 
during the exposure period were correlated to the blood Mn levels, demonstrating directly 
what was suggested by earlier result of the Department, namely that the deposition of Mn 
during a longer treatment period was not linear in time and that the functional alterations 
depended directly on brain Mn level. Taking Experiments 1 to 3 together, an up-and-down 
shape of the dependence of OF motility on the (presumable) total inner Mn dose could be 
conceived, which was in some sense similar to the published time course of CNS effect of 3-
nitropropionic acid, the mechanism of action of which is partly identical to that of Mn. 
The typically fair correlations among changes in the OF or ECoG parameters and the 
measured brain Mn levels raise the question what beyond the presence of Mn in the brain 
could be the common background. 
One such mechanism is the effect of Mn on astrocytic glutamate metabolism. Astrocytes not 
only take up glutamate and convert it to glutamine but supply that as transmitter precursor for 
both glutamatergic and GABAergic neurons. On action of Mn
2+
, both glutamate uptake and 
transformation to glutamine are reduced. The result may be the imbalance between excitation 
and inhibition, not only because of excess free glutamate but because of loss of negative 
feedback between glutamate and GABA if glutamate-uptake induced GABA release from the 
astrocytes is lost. This feedback is supposed to act mainly when excitation is elevated, such as 
in (true or modelled) epilepsy, and might provide explanation to the increased intensity of 
bursting in the Mn-treated WAG rats in Experiment 4 – but the case is more complex because 
in WAG rats systemically given GABA agonists do strengthen, and not suppress, bursting.  
The source of the bursts in WAG rats is apparently the perioral area within the somatosensory 
cortex of the rats where the motor impulses to drive the exploratory sweeping movements of 
the whiskers, with 7-12 Hz frequency, are generated. Under natural (no stimuli, no motion) or 
artificial (diminution of sensory input, this oscillatory tendency can spread the synchronic 
activity to the whole cortex. In Experiment 2 and 3, the occasional bursts appeared always 
when the animal was beyond the initial exploratory phase and was more or less motionless. 
Thus, Mn could promote bursting also by reducing the treated rats’ motility, besides the effect 
on transmitters. Inhibited function of astrocytic glutamine synthetase is probably involved 
also in human CNS disorders, including various forms of epilepsy. There are a few reports on 
the epileptogenic effect of abnormally high Mn levels in children or young adults. At this 
point it is of interest that absence seizures, to which WAG rats serve as a model also occur 
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typically during childhood. High extracellular glutamate level is universally deteriorative for 
the CNS – due to imbalance between excitation and inhibition, to excitotoxicity, and to 
oxidative stress. The dopaminergic system is especially sensitive to oxidative stress, due to 
the autooxidizing tendency of dopamine and to the presence of monoamine oxidase. 
Spontaneous locomotor activity in the OF is regulated by mesolimbic/mesocortical 
dopaminergic structures. Increased immobility in Experiment 2 and 3 was in line with the 
symptoms of heavily Mn-exposed welders suffering from Parkinson-like syndrome. 
The neuro-functional alterations observed in the Mn-treated rats were to some extent 
analogous to the effects in exposed humans, regarding both cortical electrical activity and 
motor behavior. As blood or urine Mn levels as routine measurements do not adequately 
characterize CNS damage, functional biomarkers of Mn effect, to be developed in the future 
on the basis of experimental results similar to those presented in this Thesis, may be more 
suitable for this purpose. 
 
The particular points of aims could finally be answered as follows: 
 
 The CNS effects of Mn developed in a non-monotonous way. Depending on the dose 
and length of exposure, the direction of changes varied (Experiment 1 vs. Experiment 
2 and 3); and in case of longer (8-10 weeks) exposure, the effects developed mostly in 
the first 4-5 weeks and showed little change thereafter. 
 The changes in motor behavior and in cortical electrical activity developed in parallel in 
time. Usually there was a fair correlation between numerical parameters of OF 
motility and of ECoG (total or band power), and inner Mn dose (brain Mn level) at the 
end of Mn treatment. In a few cases, the parallel changes of OF and ECoG parameters 
with blood Mn level during the treatment period could be showed. This raises the 
possibility to develop neuro-functional biomarkers of effect for human Mn poisoning. 
 The epileptogenic effect of Mn was occasionally observed in Wistar rats in Experiment 
2 and 3. In the epilepsy-prone WAG/Rij rats in Experiment 4, Mn treatment 
intensified bursting activity. 
 Beside the above points, a further noteworthy conclusion could be drawn, namely that 
intratracheal administration of Mn in form of MnO2 nanoparticles was far more 
efficient in causing high inner Mn doses than dissolved Mn applied via the drinking 
water. 
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